Wen Chyi Shyu

2.1k total citations
78 papers, 1.6k citations indexed

About

Wen Chyi Shyu is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Wen Chyi Shyu has authored 78 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pharmacology, 20 papers in Oncology and 16 papers in Pharmacology. Recurrent topics in Wen Chyi Shyu's work include Antibiotics Pharmacokinetics and Efficacy (32 papers), Analytical Methods in Pharmaceuticals (13 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Wen Chyi Shyu is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (32 papers), Analytical Methods in Pharmaceuticals (13 papers) and Pharmacogenetics and Drug Metabolism (10 papers). Wen Chyi Shyu collaborates with scholars based in United States, Germany and Japan. Wen Chyi Shyu's co-authors include Rashmi H. Barbhaiya, Kelly Pittman, W. Griffith Humphreys, Nimish N. Vachharajani, Carol Gleason, Richard B. Wilber, P. Marathe, Douglas S. Greene, Yun‐Fan Liaw and Umesh Shukla and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Wen Chyi Shyu

76 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Chyi Shyu United States 23 501 408 270 228 219 78 1.6k
Hideo Hakusui Japan 19 472 0.9× 581 1.4× 574 2.1× 152 0.7× 212 1.0× 88 1.6k
Christopher Banfield United States 30 426 0.9× 328 0.8× 515 1.9× 301 1.3× 425 1.9× 88 2.8k
John Lettieri United States 25 790 1.6× 373 0.9× 381 1.4× 377 1.7× 200 0.9× 77 1.9k
Leo Stolk Netherlands 23 623 1.2× 468 1.1× 249 0.9× 202 0.9× 164 0.7× 68 2.4k
John H. Wilton United States 21 439 0.9× 407 1.0× 198 0.7× 240 1.1× 127 0.6× 59 1.4k
Guy Montay France 25 679 1.4× 442 1.1× 658 2.4× 296 1.3× 236 1.1× 60 2.0k
Mingkang Zhong China 25 241 0.5× 448 1.1× 258 1.0× 181 0.8× 235 1.1× 100 1.7k
Donald G. Musson United States 27 553 1.1× 430 1.1× 127 0.5× 192 0.8× 106 0.5× 78 1.8k
Douglas S. Greene United States 20 487 1.0× 236 0.6× 219 0.8× 70 0.3× 268 1.2× 66 1.4k
J. Paul Monk United States 27 556 1.1× 643 1.6× 838 3.1× 295 1.3× 77 0.4× 58 3.3k

Countries citing papers authored by Wen Chyi Shyu

Since Specialization
Citations

This map shows the geographic impact of Wen Chyi Shyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Chyi Shyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Chyi Shyu more than expected).

Fields of papers citing papers by Wen Chyi Shyu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Chyi Shyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Chyi Shyu. The network helps show where Wen Chyi Shyu may publish in the future.

Co-authorship network of co-authors of Wen Chyi Shyu

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Chyi Shyu. A scholar is included among the top collaborators of Wen Chyi Shyu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Chyi Shyu. Wen Chyi Shyu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xiaofei, Yuexian Li, Lawrence H. Cohen, et al.. (2020). Biotransformation Pathways and Metabolite Profiles of Oral [14C]Alisertib (MLN8237), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors. Drug Metabolism and Disposition. 48(3). 217–229. 13 indexed citations
2.
Wolenski, Francis S., et al.. (2017). CYP Suppression in Human Hepatocytes by Monomethyl Auristatin E, the Payload in Brentuximab Vedotin (Adcetris®), is Associated with Microtubule Disruption. European Journal of Drug Metabolism and Pharmacokinetics. 43(3). 347–354. 6 indexed citations
3.
Huck, Jessica J., Mengkun Zhang, Jerome T. Mettetal, et al.. (2014). Translational Exposure–Efficacy Modeling to Optimize the Dose and Schedule of Taxanes Combined with the Investigational Aurora A Kinase Inhibitor MLN8237 (Alisertib). Molecular Cancer Therapeutics. 13(9). 2170–2183. 27 indexed citations
4.
Kogame, Akifumi, Yoshihiko Tagawa, Sachio Shibata, et al.. (2013). Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice. Drug Metabolism and Disposition. 41(4). 727–734. 15 indexed citations
5.
Lin, Chih Hung, Sen‐Yung Hsieh, I-Shyan Sheen, et al.. (2001). Genome-wide hypomethylation in hepatocellular carcinogenesis.. PubMed. 61(10). 4238–43. 186 indexed citations
6.
Srinivas, Nuggehally R., Russell Weiner, Karen Berry, Lee K. Tay, & Wen Chyi Shyu. (1998). Pharmacokinetics and Pharmacodynamics of CTLA4Ig (BMS‐188667), a Novel Immunosuppressive Agent, After Subcutaneous and Intravenous Administration to Mice. Pharmacy and Pharmacology Communications. 4(7). 355–360. 1 indexed citations
7.
Srinivas, Nuggehally R., et al.. (1998). High-performance liquid chromatographic–electrochemical assay for the quantitation of BMS-181885 in monkey plasma. Journal of Chromatography B Biomedical Sciences and Applications. 705(2). 317–322. 1 indexed citations
8.
9.
Shyu, Wen Chyi, et al.. (1998). Absolute Bioavailability and Dose Proportionality of BMS-181885, an Antimigraine Agent, Following the Administration of Single Intranasal Doses to Cynomolgus Monkeys. Journal of Pharmaceutical Sciences. 87(9). 1170–1172. 3 indexed citations
10.
Vachharajani, Nimish N., et al.. (1998). Pharmacokinetic Assessment of the Sites of First-pass Metabolism of BMS- 181101, an Antidepressant Agent, in Rats. Journal of Pharmacy and Pharmacology. 50(3). 275–278. 2 indexed citations
11.
Srinivas, Nuggehally R., Wen Chyi Shyu, James Lee, Douglas S. Greene, & Rashmi H. Barbhaiya. (1997). Lack of effect of food on the steady state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects. Biopharmaceutics & Drug Disposition. 18(7). 585–593. 1 indexed citations
12.
Yeh, Chih‐Ching, et al.. (1997). Quantitative assessment of serum hepatitis B virus DNA: comparison between two different methods. International Hepatology Communications. 7(3). 159–167. 7 indexed citations
13.
14.
Shyu, Wen Chyi, Elizabeth Morgenthien, & Rashmi H. Barbhaiya. (1996). Pharmacokinetics of butorphanol nasal spray in patients with renal impairment. British Journal of Clinical Pharmacology. 41(5). 397–402. 8 indexed citations
15.
Srinivas, Nuggehally R., Wen Chyi Shyu, David Upmalis, James Lee, & Rashmi H. Barbhaiya. (1995). Lack of Pharmacokinetic Interaction Between Butorphanol Tartrate Nasal Spray and Sumatriptan Succinate. The Journal of Clinical Pharmacology. 35(4). 432–437. 10 indexed citations
16.
Srinivas, Nuggehally R., et al.. (1995). High‐performance liquid chromatographic assay for the quantitation of nadolol in human plasma using fluorescence detection. Biomedical Chromatography. 9(2). 75–79. 5 indexed citations
17.
Shyu, Wen Chyi, Kenneth A. Pittman, D. Robinson, & Rashmi H. Barbhaiya. (1993). Multiple-dose phase I study of transnasal butorphanol. Clinical Pharmacology & Therapeutics. 54(1). 34–41. 23 indexed citations
18.
Shyu, Wen Chyi, Kelly Pittman, Richard B. Wilber, Gary R. Matzke, & Rashmi H. Barbhaiya. (1991). Pharmacokinetics of Cefprozil in Healthy Subjects and Patients with Renal Impairment. The Journal of Clinical Pharmacology. 31(4). 362–371. 13 indexed citations
19.
Barbhaiya, Rashmi H., et al.. (1987). High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine. Antimicrobial Agents and Chemotherapy. 31(1). 55–59. 86 indexed citations
20.
Shyu, Wen Chyi, C H Nightingale, Richard Quintiliani, & Karen S. Oles. (1981). Stability of Cephalosporins in Commercial Sera. The Journal of Infectious Diseases. 144(5). 483–483.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideo Hakusui Breakdown of academic impact, for papers by Christopher Banfield Breakdown of academic impact, for papers by John Lettieri Breakdown of academic impact, for papers by Leo Stolk Breakdown of academic impact, for papers by John H. Wilton Breakdown of academic impact, for papers by Guy Montay Breakdown of academic impact, for papers by Mingkang Zhong Breakdown of academic impact, for papers by Donald G. Musson Breakdown of academic impact, for papers by Douglas S. Greene Breakdown of academic impact, for papers by J. Paul Monk
Rankless by CCL
2026